NextGenNK, a Competence Center for the development of next generation NK cell-based cancer immunotherapies. The Center is coordinated by Karolinska Institutet and collaborates with the Karolinska University Hospital and prominent national and international industrial partners. The Center is jointly funded by Vinnova, KI, and the Industrial partners.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Stockholm, Se
- Industry
- Research
- Keywords
- Elicera Therapeutics AB.
- HQ
- Stockholm
Nextgennk Questions
Nextgennk's website is https://ki.se/en/research/nextgennk
Nextgennk's LinkedIn profile is https://se.linkedin.com/company/nextgennk
Nextgennk has
1 employees.
View email and phone details for 1
employees at Nextgennk.
Nextgennk's industry is
Research
Nextgennk's top competitors are
Oncostart,
Elicera Therapeutics Ab,
Voxlbio,
Spatialist,
Indicell,
3h Biomedical Ab,
Precision Immunotherapy Alliance, Prima,
Campus Flemingsberg,
Ccrm Nordic,
Vycellix.
Nextgennk's categories are Research
Nextgennk's founding year is 2020
